Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Multivalent Vaccines Market Report 2024

Multivalent Vaccines Global Market Report 2025 – By Type (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Disease (Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus), By Route Of Administration (Oral, Injectable), By Age Group (Pediatrics, Adults, Geriatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

Multivalent Vaccines Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Multivalent Vaccines Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Multivalent Vaccines Market Definition

Multivalent vaccines are vaccines designed to protect against multiple strains or types of a single pathogen, or against several different pathogens, in a single dose. By including antigens from various strains or diseases, these vaccines generate immunity against several targets simultaneously, offering broader protection compared to monovalent vaccines, which focus on a single strain or pathogen.

The main types of multivalent vaccines are Conjugate Vaccines, Inactivated And Subunit Vaccines, live attenuated vaccines, toxoid vaccines, and recombinant vaccines. Conjugate vaccines link a weaker antigen to a stronger one, enhancing immune recognition and effectiveness, particularly for bacterial diseases. These are used for various diseases such as influenza, pneumonia, hepatitis, meningitis, and rotavirus, and they are administered through different routes, including oral and injectable. It is provided to several age groups, such as pediatrics, adults, and geriatrics, and sold through various distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Multivalent Vaccines Market Segmentation

The multivalent vaccinesmarket covered in this report is segmented –

1) By Type: Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines

2) By Disease: Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus

3) By Route Of Administration: Oral, Injectable

4) By Age Group: Pediatrics, Adults, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines, Protein Conjugate Vaccines

2) By Inactivated And Subunit Vaccines: Inactivated Whole Virus Vaccines, Subunit Protein Vaccines, Virus-Like Particle Vaccines

3) By Live Attenuated Vaccines: Live Attenuated Bacterial Vaccines, Live Attenuated Viral Vaccines

4) By Toxoid Vaccines: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

5) By Recombinant Vaccines: Recombinant Protein Vaccines, Recombinant DNA Vaccines

Multivalent Vaccines Market Size and growth rate 2025 to 2029: Graph

Multivalent Vaccines Market Size 2025 And Growth Rate

The multivalent vaccines market size has grown strongly in recent years. It will grow from $8.37 billion in 2024 to $9.2 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising public awareness for vaccination, increasing government support, increasing demand for pediatric multivalent vaccines, increasing funding for vaccine research, and rising demand for multivalent vaccines.

Multivalent Vaccines Market Growth Forecast

The multivalent vaccines market size is expected to see strong growth in the next few years. It will grow to $13.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rising incidence of infectious illnesses, increasing numbers of geriatric population, increasing government and private sector investment, growing focus on vaccine safety and effectiveness, and growing focus on therapeutic vaccines. Major trends in the forecast period include greater emphasis on combination vaccines, integration of digital health technologies, development in mRNA technology, development of personalized vaccines, and increase in research activities.

Book your 30 minutes free consultation with our research experts

Contact Us

Multivalent Vaccines Market Driver: Rising Infectious Disease Incidences Drive Growth In The Multivalent Vaccine Market

The rising incidences of infectious diseases are expected to propel the growth of the multivalent vaccines market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that spread through direct contact or contaminated surfaces, air, or water and can range from mild to severe. Global travel accelerates the spread of infectious diseases by allowing pathogens to quickly cross borders and infect new populations. Multivalent vaccines provide wider protection in infectious diseases by targeting multiple pathogen strains in one dose, cutting down the need for separate shots. This broad coverage boosts herd immunity and lowers disease prevalence, enhancing public health. For instance, in April 2024, according to the report published by TravelHealthPro, a UK-based website supported by the UK Health Security Agency, the UK reported 2,004 malaria cases in 2023, marking an increase from the 1,369 imported cases reported in 2022. Therefore, the rising incidences of infectious diseases are driving the growth of the multivalent vaccines market.

Global Multivalent Vaccines Market Major Players

Major companies operating in the multivalent vaccines market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Moderna Inc., BioNTech SE, Zydus Lifesciences Limited, CSL Seqirus, Sinovac Biotech Ltd., GC Biopharma corp., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Indian Immunologicals Ltd., Bavarian Nordic, Panacea Biotec Ltd., WestVac Biopharma Co. Ltd., VBI Vaccines Inc.

Global Multivalent Vaccines Market Trend: Advancements In Pentavalent Vaccines Enhance Efficiency And Sustainability In Immunization

Major companies operating in the multivalent vaccines market are focused on developing advanced pentavalent vaccines to improve overall public health outcomes by offering broader protection in a single dose. A pentavalent vaccine is a multivalent vaccine designed to protect against five distinct pathogens or strains. Combining these protections into a single vaccine simplifies immunization schedules and enhances overall vaccine coverage. For instance, in December 2023, Panacea Biotec Ltd., an India-based biotechnology company, launched EasyFourPol. This vaccine is the world’s first fully liquid vaccine, protecting against five serious diseases such as diphtheria, tetanus, pertussis, polio, and invasive infections from Haemophilus influenzae Type B. This ready-to-use combination vaccine eliminates the need for preparation by healthcare workers, streamlining the vaccination process. It offers the same level of protection as single-antigen vaccines, reduces the number of clinic visits for children, and lowers overall immunization costs. Additionally, it enhances vaccination efficiency and minimizes environmental impact by reducing the need for vials, syringes, and packaging.

Multivalent Vaccines Market Merger And Acquisition: AstraZeneca Acquired Icosavax To Strengthen RSV Vaccine Pipeline And Expand Multivalent Vaccine Development

In February 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Icosavax Inc. for $1.1 billion. Through this acquisition, AstraZeneca enhances its late-stage pipeline with IVX-A12, boosting its presence in the RSV vaccine sector. The deal also brings Icosavax's protein design and VLP expertise, providing a platform for developing more multivalent vaccines for respiratory viruses. Icosavax Inc. is a US-based biotechnology company that specializes in developing a protein virus-like particle (VLP) platform that allows for the creation of multivalent vaccines.

Regional Outlook For The Global Multivalent Vaccines Market

North America was the largest region in the multivalent vaccines market in 2024. The regions covered in the multivalent vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multivalent vaccines market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Multivalent Vaccines Market?

The multivalent vaccines market consists of sales of bivalent vaccines, trivalent vaccines, and polyvalent vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Multivalent Vaccines Industry?

The multivalent vaccines market research report is one of a series of new reports from The Business Research Company that provides multivalent vaccines market statistics, including multivalent vaccines industry global market size, regional shares, competitors with a multivalent vaccines market share, detailed multivalent vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the multivalent vaccines industry. These multivalent vaccines market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Multivalent Vaccines Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $9.2 billion
Revenue Forecast In 2034 $13.32 billion
Growth Rate CAGR of 9.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines
2) By Disease: Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus
3) By Route Of Administration: Oral, Injectable
4) By Age Group: Pediatrics, Adults, Geriatrics
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines, Protein Conjugate Vaccines
2) By Inactivated And Subunit Vaccines: Inactivated Whole Virus Vaccines, Subunit Protein Vaccines, Virus-Like Particle Vaccines
3) By Live Attenuated Vaccines: Live Attenuated Bacterial Vaccines, Live Attenuated Viral Vaccines
4) By Toxoid Vaccines: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines
5) By Recombinant Vaccines: Recombinant Protein Vaccines, Recombinant DNA Vaccines
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Moderna Inc., BioNTech SE, Zydus Lifesciences Limited, CSL Seqirus, Sinovac Biotech Ltd., GC Biopharma corp., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Indian Immunologicals Ltd., Bavarian Nordic, Panacea Biotec Ltd., WestVac Biopharma Co. Ltd., VBI Vaccines Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Multivalent Vaccines Market Characteristics

    3. Multivalent Vaccines Market Trends And Strategies

    4. Multivalent Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Multivalent Vaccines Growth Analysis And Strategic Analysis Framework

    5.1. Global Multivalent Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Multivalent Vaccines Market Growth Rate Analysis

    5.4. Global Multivalent Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Multivalent Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Multivalent Vaccines Total Addressable Market (TAM)

    6. Multivalent Vaccines Market Segmentation

    6.1. Global Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Conjugate Vaccines

    Inactivated And Subunit Vaccines

    Live Attenuated Vaccines

    Toxoid Vaccines

    Recombinant Vaccines

    6.2. Global Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Influenza

    Pneumonia

    Hepatitis

    Meningitis

    Rotavirus

    6.3. Global Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Injectable

    6.4. Global Multivalent Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pediatrics

    Adults

    Geriatrics

    6.5. Global Multivalent Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    6.6. Global Multivalent Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Polysaccharide Conjugate Vaccines

    Protein Conjugate Vaccines

    6.7. Global Multivalent Vaccines Market, Sub-Segmentation Of Inactivated And Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Inactivated Whole Virus Vaccines

    Subunit Protein Vaccines

    Virus-Like Particle Vaccines

    6.8. Global Multivalent Vaccines Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Live Attenuated Bacterial Vaccines

    Live Attenuated Viral Vaccines

    6.9. Global Multivalent Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Diphtheria Toxoid Vaccines

    Tetanus Toxoid Vaccines

    6.10. Global Multivalent Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Recombinant Protein Vaccines

    Recombinant DNA Vaccines

    7. Multivalent Vaccines Market Regional And Country Analysis

    7.1. Global Multivalent Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Multivalent Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Multivalent Vaccines Market

    8.1. Asia-Pacific Multivalent Vaccines Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Multivalent Vaccines Market

    9.1. China Multivalent Vaccines Market Overview

    9.2. China Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Multivalent Vaccines Market

    10.1. India Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Multivalent Vaccines Market

    11.1. Japan Multivalent Vaccines Market Overview

    11.2. Japan Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Multivalent Vaccines Market

    12.1. Australia Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Multivalent Vaccines Market

    13.1. Indonesia Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Multivalent Vaccines Market

    14.1. South Korea Multivalent Vaccines Market Overview

    14.2. South Korea Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Multivalent Vaccines Market

    15.1. Western Europe Multivalent Vaccines Market Overview

    15.2. Western Europe Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Multivalent Vaccines Market

    16.1. UK Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Multivalent Vaccines Market

    17.1. Germany Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Multivalent Vaccines Market

    18.1. France Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Multivalent Vaccines Market

    19.1. Italy Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Multivalent Vaccines Market

    20.1. Spain Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Multivalent Vaccines Market

    21.1. Eastern Europe Multivalent Vaccines Market Overview

    21.2. Eastern Europe Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Multivalent Vaccines Market

    22.1. Russia Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Multivalent Vaccines Market

    23.1. North America Multivalent Vaccines Market Overview

    23.2. North America Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Multivalent Vaccines Market

    24.1. USA Multivalent Vaccines Market Overview

    24.2. USA Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Multivalent Vaccines Market

    25.1. Canada Multivalent Vaccines Market Overview

    25.2. Canada Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Multivalent Vaccines Market

    26.1. South America Multivalent Vaccines Market Overview

    26.2. South America Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Multivalent Vaccines Market

    27.1. Brazil Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Multivalent Vaccines Market

    28.1. Middle East Multivalent Vaccines Market Overview

    28.2. Middle East Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Multivalent Vaccines Market

    29.1. Africa Multivalent Vaccines Market Overview

    29.2. Africa Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Multivalent Vaccines Market Competitive Landscape And Company Profiles

    30.1. Multivalent Vaccines Market Competitive Landscape

    30.2. Multivalent Vaccines Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    31. Multivalent Vaccines Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. GlaxoSmithKline plc

    31.3. Boehringer Ingelheim International GmbH

    31.4. Moderna Inc.

    31.5. BioNTech SE

    31.6. Zydus Lifesciences Limited

    31.7. CSL Seqirus

    31.8. Sinovac Biotech Ltd.

    31.9. GC Biopharma corp.

    31.10. Emergent BioSolutions Inc.

    31.11. Serum Institute of India Pvt. Ltd.

    31.12. Indian Immunologicals Ltd.

    31.13. Bavarian Nordic

    31.14. Panacea Biotec Ltd.

    31.15. WestVac Biopharma Co. Ltd.

    32. Global Multivalent Vaccines Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Multivalent Vaccines Market

    34. Recent Developments In The Multivalent Vaccines Market

    35. Multivalent Vaccines Market High Potential Countries, Segments and Strategies

    35.1 Multivalent Vaccines Market In 2029 - Countries Offering Most New Opportunities

    35.2 Multivalent Vaccines Market In 2029 - Segments Offering Most New Opportunities

    35.3 Multivalent Vaccines Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Multivalent Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Multivalent Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Multivalent Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Multivalent Vaccines Market, Sub-Segmentation Of Inactivated And Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Multivalent Vaccines Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Multivalent Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Multivalent Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Multivalent Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Multivalent Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: Sanofi SA Financial Performance
  • Table 84: AstraZeneca plc Financial Performance
  • Table 85: Abbott Laboratories Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Multivalent Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Multivalent Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Multivalent Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Multivalent Vaccines Market, Sub-Segmentation Of Inactivated And Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Multivalent Vaccines Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Multivalent Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Multivalent Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Multivalent Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Multivalent Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Multivalent Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Multivalent Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Multivalent Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: Sanofi SA Financial Performance
  • Figure 84: AstraZeneca plc Financial Performance
  • Figure 85: Abbott Laboratories Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DTP Vaccines Global Market Report 2025 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

H1N1 Vaccine Global Market Report 2025 – By Product Type( Inactivated Vaccine, Live Attenuated Vaccine ), By Route Of Administration( Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination ), By End Users( Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Meningococcal Vaccines Global Market Report 2025 – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Children, Adolescents and Young Adults, Adults), By Distribution Channel ( (Pharmacies, Community Clinics, Public Health Agencies, Other Channels), By End user (Hospitals, Research, Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vaccine Contract Manufacturing Global Market Report 2025 – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines), By Process (Downstream, Upstream), By Scale Of Operation (Preclinical, Clinical, Commercial), By End-Use (Human Use, Veterinary) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Companion Animal Veterinary Vaccines Global Market Report 2025 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Vaccines Global Market Report 2025 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Multivalent Vaccines market?

Multivalent vaccines are vaccines designed to protect against multiple strains or types of a single pathogen, or against several different pathogens, in a single dose. By including antigens from various strains or diseases, these vaccines generate immunity against several targets simultaneously, offering broader protection compared to monovalent vaccines, which focus on a single strain or pathogen. For further insights on the Multivalent Vaccines market, request a sample here

How will the Multivalent Vaccines market drivers and restraints affect the market dynamics? What forces will shape the Multivalent Vaccines industry going forward?

The Multivalent Vaccines market major growth driver - Rising Infectious Disease Incidences Drive Growth In The Multivalent Vaccine Market. For further insights on the Multivalent Vaccines market, request a sample here

What is the forecast market size or the forecast market value of the Multivalent Vaccines market?

The Multivalent Vaccines market size has grown strongly in recent years. The multivalent vaccines market size has grown strongly in recent years. It will grow from $8.37 billion in 2024 to $9.2 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising public awareness for vaccination, increasing government support, increasing demand for pediatric multivalent vaccines, increasing funding for vaccine research, and rising demand for multivalent vaccines. The multivalent vaccines market size is expected to see strong growth in the next few years. It will grow to $13.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rising incidence of infectious illnesses, increasing numbers of geriatric population, increasing government and private sector investment, growing focus on vaccine safety and effectiveness, and growing focus on therapeutic vaccines. Major trends in the forecast period include greater emphasis on combination vaccines, integration of digital health technologies, development in mRNA technology, development of personalized vaccines, and increase in research activities. For further insights on the Multivalent Vaccines market, request a sample here

How is the Multivalent Vaccines market segmented?

The multivalent vaccinesmarket covered in this report is segmented –
1) By Type: Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines
2) By Disease: Influenza, Pneumonia, Hepatitis, Meningitis, Rotavirus
3) By Route Of Administration: Oral, Injectable
4) By Age Group: Pediatrics, Adults, Geriatrics
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines, Protein Conjugate Vaccines
2) By Inactivated And Subunit Vaccines: Inactivated Whole Virus Vaccines, Subunit Protein Vaccines, Virus-Like Particle Vaccines
3) By Live Attenuated Vaccines: Live Attenuated Bacterial Vaccines, Live Attenuated Viral Vaccines
4) By Toxoid Vaccines: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines
5) By Recombinant Vaccines: Recombinant Protein Vaccines, Recombinant DNA Vaccines For further insights on the Multivalent Vaccines market, request a sample here

Which region has the largest share of the Multivalent Vaccines market? What are the other regions covered in the report?

North America was the largest region in the multivalent vaccines market in 2024. The regions covered in the multivalent vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Multivalent Vaccines market, request a sample here.

Who are the major players in the Multivalent Vaccines market?

Major companies operating in the multivalent vaccines market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Moderna Inc., BioNTech SE, Zydus Lifesciences Limited, CSL Seqirus, Sinovac Biotech Ltd., GC Biopharma corp., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Indian Immunologicals Ltd., Bavarian Nordic, Panacea Biotec Ltd., WestVac Biopharma Co. Ltd., VBI Vaccines Inc. . For further insights on the Multivalent Vaccines market, request a sample here.

What are the key trends in the Multivalent Vaccines market?

Major trends in the Multivalent Vaccines market include Advancements In Pentavalent Vaccines Enhance Efficiency And Sustainability In Immunization. For further insights on the Multivalent Vaccines market, request a sample here.

What are the major opportunities in the Multivalent Vaccines market? What are the strategies for the Multivalent Vaccines market?

For detailed insights on the major opportunities and strategies in the Multivalent Vaccines market, request a sample here.

How does the Multivalent Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Multivalent Vaccines's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Multivalent Vaccines industry?

For detailed insights on the mergers and acquisitions in the Multivalent Vaccines industry, request a sample here.

What are the key dynamics influencing the Multivalent Vaccines market growth? SWOT analysis of the Multivalent Vaccines market.

For detailed insights on the key dynamics influencing the Multivalent Vaccines market growth and SWOT analysis of the Multivalent Vaccines industry, request a sample here.